News

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Vish Seshadri, Ph.D., Chief Executive Officer, and Madhav ...
The Hemophilia B treatment landscape is entering a new era, marked by disruptive innovation, curative potential, and renewed global attention. Once viewed as a lifelong burden requiring constant ...
More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...
The body’s immune system provides protection against harmful viruses, bacteria, and other foreign bodies. However, in some individuals, this protective mechanism can turn on the body itself.Such is ...
Abscess If you notice a painful bump on the roof of your mouth, it could be an abscess—an infection that forms when bacteria ...
Advancements in gene therapy for Duchenne muscular dystrophy (DMD) have improved the outlook for some patients, but further ...
Gene therapy is once again in the spotlight—brought there by news reports of "adverse events," including half a dozen deaths, involving participants in several separate clinical trials.
Cytek Biosciences, Inc. (NASDAQ:CTKB) has announced the launch of its latest innovation, the Cytek Aurora Evo system, marking ...
Fetal bovine serum (FBS) has long served as a foundational input for cell culture, tissue engineering, and biomanufacturing.
A Laurel, Nebraska, man convicted of murdering four Laurel residents in August 2022 might testify against his wife for her ...
In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) ...
DelveInsight’s Natural Killer (NK)-Cell Lymphoma Pipeline report depicts a robust space with 100+ active players working to develop 140+ pipeline therapies for Natural Killer (NK)-Cell Lymphoma ...